title: The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
authors.affiliation: Johns Hopkins Oncology Center, Baltimore, Maryland.
authors.forename: S J
authors.initials: SJ
authors.lastname: Noga
authors.forename: J
authors.initials: J
authors.lastname: Davis
authors.forename: K
authors.initials: K
authors.lastname: Schepers
authors.forename: L
authors.initials: L
authors.lastname: Eby
authors.forename: R J
authors.initials: RJ
authors.lastname: Berenson
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D018952:Antigens, CD34; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D003114:Colony-Forming Units Assay; D006086:Graft vs Host Disease / Q000517:prevention & control; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008212:Lymphocyte Depletion; D008214:Lymphocytes / Q000166:cytology* / Q000276:immunology; D014184:Transplantation, Homologous
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34